Descrizione

DNA sequencing is a laboratory technique used to determine the exact sequence of bases (UN, C, G, and T) in a DNA molecule. The DNA base sequence carries the information a cell needs to assemble protein and RNA molecules. DNA sequence information is important to scientists investigating the functions of genes. A study by StrategyHelix indicates that the global DNA sequencing market is expected to increase by US$ 28.7 miliardi da 2022 A 2028, ottenendo un CAGR di 18.1% durante il periodo di previsione.

Il rapporto fornisce dati aggiornati sulle dimensioni del mercato per il periodo 2018-2021 e previsione a 2028 covering key market aspects like sales value for DNA sequencing. The global DNA sequencing market is segmented on the basis of product, sequencing type, applicazione, e regione. In base al prodotto, the global DNA sequencing market is categorized into sequencing services, sequencing instruments, sequencing consumables, sequencing informatics. Sequencing services held the highest share in the global dna sequencing market. Tuttavia, the sequencing informatics segment is forecast to register the highest CAGR during the forecast period 2022 – 2028. On the basis of sequencing type, the global DNA sequencing market has been segmented into next generation sequencing (NGS), sanger sequencing, altri. The NGS segment captured the largest share of the market in 2021. Per applicazione, the global DNA sequencing market has been segmented into applied, clinical, research. In termini di geografia, the global DNA sequencing market has been segmented into Asia Pacific, Europa, Nord America, Rest of the World (RoW). North America held the largest revenue share in 2021.

The global DNA sequencing market is highly competitive. As of 2021, the major players in the global DNA sequencing market were Adaptive Biotechnologies Corp., Agilent Technologies Inc., Ambry Genetics Corporation, BD (Becton Dickinson and Company), Berry Genomics Co. Ltd., BGI Group, Biodesix Inc., CareDx Inc., Centogene AG, Danaher Corporation, Devyser Diagnostics AB, Illumina Inc., Macrogen Inc., Merck KGaA, myDNA Inc., Natera Inc., NeoGenomics Laboratories Inc., New England Biolabs Inc., NGeneBio Co. Ltd., Oxford Nanopore Technologies Limited, Pacific Biosciences of California Inc., PerkinElmer Inc., Personalis Inc., Qiagen N.V., Quest Diagnostics Inc., Roche Holding AG, SOPHiA GENETICS, TAKARA BIO INC., Thermo Fisher Scientific Inc.

Il rapporto è una risorsa inestimabile per le aziende e le organizzazioni attive in questo settore. It provides a cohesive picture of the DNA sequencing market to help drive informed decision making for industry executives, decisori politici, accademico, e analisti.

Ambito del rapporto

Prodotto: sequencing services, sequencing instruments, sequencing consumables, sequencing informatics
Sequencing type: next generation sequencing (NGS), sanger sequencing, altri
Applicazione: applied, clinical, research
Regione: Asia Pacifico, Europa, Nord America, Rest of the World (RoW)
Anni considerati: la presente relazione copre il periodo 2018 A 2028

Principali vantaggi per gli stakeholder

– Get a comprehensive picture of the global DNA sequencing market
– Individuare i settori in crescita e le tendenze per gli investimenti

Sommario

Parte 1. introduzione
– Ambito dello studio
– Periodo di studio
– Ambito geografico
– Metodologia di ricerca
Parte 2. DNA sequencing market overview
Parte 3. Ripartizione del mercato per prodotto
– Sequencing services
– Sequencing instruments
– Sequencing consumables
– Sequencing informatics
Parte 4. Market breakdown by sequencing type
– Next generation sequencing (NGS)
– Sanger sequencing
– Altri
Parte 5. Market breakdown by application
– Applied
– Clinical
– Research
Parte 6. Market breakdown by region
– Asia Pacifico
– Europa
– Nord America
– Rest of the World (RoW)
Parte 7. Aziende chiave
– Adaptive Biotechnologies Corp.
– Agilent Technologies, Inc.
– Ambry Genetics Corporation
– BD (Becton, Dickinson and Company)
– Berry Genomics Co., Ltd.
– BGI Group
– Biodesix, Inc.
– CareDx, Inc.
– Centogene AG
– Danaher Corporation
– Devyser Diagnostics AB
– Illumina, Inc.
– Macrogen, Inc.
– Merck KGaA
– myDNA Inc.
– Natera, Inc.
– NeoGenomics Laboratories, Inc.
– New England Biolabs, Inc.
– NGeneBio Co., Ltd.
– Oxford Nanopore Technologies Limited
– Pacific Biosciences of California, Inc.
– PerkinElmer, Inc.
– Personalis, Inc.
– Qiagen N.V.
– Quest Diagnostics Inc.
– Roche Holding AG
– SOPHiA GENETICS
– TAKARA BIO INC.
– Thermo Fisher Scientific Inc.
Informazioni su StrategyHelix
Disclaimer